top of page
SCROLL
what is innovatio nd2?
It is a test of specific biomarkers linked to the onset of Nephropathy (Kidney Disease) in type 2 diabetic patients.
​
INNOVATIO ND2™: is a test (ELISA) developed and validated by Omics Global Solutions under a technological license with Proteomics International and its PromarkerD ™. mass spectrometry platform.
With this technology, the risk of having Diabetic Kidney Disease is identified at the time of taking the test, in addition to quantifying the risk of developing this condition in the future, up to 4 years in advance.
What is the relationship between diabetes and dialysis?
bottom of page